Company Profiles

driven by the PitchBook Platform

Tragara Pharmaceuticals

Description

Developer of proprietary medicines for the treatment of cancer. The company is the developer of TGO2, an oral multi-kinase inhibitor with anti-tumor properties. The company is focused on development of therapies for a range of cancers, including non-small-cell lung cancer, breast cancer and pancreatic cancer.

2005

Founded

PRIVATE

Status

1-10

Employees

Later Stage VC

Latest Deal Type

$3.26M

Latest Deal Amount

$85.3M

Total Amount Raised

Description

Developer of proprietary medicines for the treatment of cancer. The company is the developer of TGO2, an oral multi-kinase inhibitor with anti-tumor properties. The company is focused on development of therapies for a range of cancers, including non-small-cell lung cancer, breast cancer and pancreatic cancer.

Website:

www.tragarapharma.com

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Drug Discovery

Primary Office

3152 Lionshead Avenue Carlsbad, CA 92010United States +1 (760) 208-6900
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Tragara Pharmaceuticals's full profile, request a free trial.

Tragara Pharmaceuticals Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Tragara Pharmaceuticals Cap Table

Stock# of Shares
Authorized
Par ValueDividend Rate (%)Original
Issue Price
LiquidationLiquidation
Pref. Multiple
Conversion
Price
% Owned

Tragara Pharmaceuticals Investors (8)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
Domain AssociatesVenture CapitalMinority000 0000000 0000
Lightstone VenturesVenture CapitalMinority000 0000000 0000
Mitsubishi InternationalPE/BuyoutMinority000 0000000 0000
MorgenthalerVenture CapitalMinority000 0000000 0000
Multiple Myeloma Research FoundationCorporationMinority000 0000000 0000
Domain Associates Venture Capital
Lightstone Ventures Venture Capital
Mitsubishi International PE/Buyout
Morgenthaler Venture Capital
Multiple Myeloma Research Foundation Corporation

Tragara Pharmaceuticals Executive Team (5)

NameTitleBoard
Seat
Contact
Info
Thomas EstokPresident, Board Member & Chief Executive Officer
Dennis BilskiChief Financial Officer
Tracy Parrott JDCo-Founder & Chief Operating Officer
Mary SytoDirector, Clinical Operations
Robert Mansfield Ph.DSenior Director, Manufacturing
Thomas Estok President, Board Member & Chief Executive Officer
Dennis Bilski Chief Financial Officer
Tracy Parrott JD Co-Founder & Chief Operating Officer
Mary Syto Director, Clinical Operations
Robert Mansfield Ph.D Senior Director, Manufacturing

Tragara Pharmaceuticals Board Members (6)

NameRepresentingRoleSinceContact
Info
Alain Schreiber MDProQuest InvestmentsPartner000 0000
Eckard Weber MDDomain AssociatesPartner000 0000
Evgeny Zaytsev Ph.DRusnanoMedInvestManaging Partner000 0000
Kim Kamdar Ph.DDomain AssociatesPartner000 0000
R. Chris Christoffersen Ph.DMorgenthalerPartner, Life Sciences000 0000
Alain Schreiber MD Partner ProQuest Investments
Eckard Weber MD Partner Domain Associates
Evgeny Zaytsev Ph.D Managing Partner RusnanoMedInvest
Kim Kamdar Ph.D Partner Domain Associates
R. Chris Christoffersen Ph.D Partner, Life Sciences Morgenthaler
Request full access to PitchBook